Skip to content
naulon
Not checkedNot checked for notices yet.

Bicanalicular lacrimal intubation as a primary surgical treatment for nasolacrimal duct obstruction in children

Raafat M Abdelrahman Abdallah

Journal of the Egyptian Ophthalmological Society · 2016

doi:10.4103/2090-0686.192742 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Purpose The purpose of this study was to evaluate the success of bicanalicular lacrimal intubation as a primary treatment in cases of epiphora caused by congenital nasolacrimal duct obstruction in children up to 6 years of age. Patients and methods A prospective surgical intervention case series study was carried out in the Ophthalmology Department of Minia University Hospital. Forty-six eyes of 43 children with epiphora (dated since birth or shortly after) were enroled in this study. A bicanalicular lacrimal silicon tube was introduced through the nasolacrimal duct to the nose. Results In this study, the primary lacrimal intubation was successful in 40 eyes out of 46 eyes (87%). For children aged 1–2 years, primary intubation was successful in 22 eyes out of 24 (91.6%), and for those aged 2–4 years it was successful in 12 eyes out of 14 (85.7%). On the other hand, for children aged between 4 and 6 years, the procedure was less successful: six eyes out of eight (75%). Improvement of symptoms occurred in two eyes out of four (50%) when the tubes were removed early, and this rate increased to 90.9% in 20 out of 22 eyes when the tubes were retained for up to 3–6 months and to 90% in 18 out of 20 eyes when the tubes were retained for up to 6–12 months. Conclusion Bicanalicular lacrimal intubation is a successful treatment for children with nasolacrimal duct obstruction, and the younger the age of the children the higher the success rate.

Abstract licence: CC BY-NC-SA

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.